Dr. Muhammad Saad Saad Hamid, MD

Dr. Hamid practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Hamid's NPI, 1508276916, was assigned on May 7, 2014. Dr. Hamid holds Tennessee license MD0000061018.

Dr. Hamid's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Hamid's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Hamid is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Hamid to 1 more clinical lab and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamid practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hamid's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Hamid's licenses on file in 2 states: Tennessee and Georgia.

CMS data shows 76 Medicare services from Dr. Hamid across 2 procedure codes in 2024, for 35 Medicare patients. Medicare paid $5,591 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Dr. Hamid in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 57% have high cholesterol. 57% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hamid's median patient age at 70, with 58% women.

In 2024, Dr. Hamid wrote 191 Medicare Part D claims for 16 patients. 66% of them were for generic drugs. CMS names the drug for 60 of them, across 4 drugs with 11 or more claims each, at $1,319,220 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Hamid for performance year 2024, reported as part of a group. Dr. Hamid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hamid as offering telehealth.

CMS Open Payments shows 56 general payments to Dr. Hamid from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. AstraZeneca Pharmaceuticals LP paid the most, $360.